Ebola Literature

Acharibasam JW, Chireh B, Menegesha HG. Assessing anxiety, depression and insomnia symptoms among Ebola survivors in Africa: a meta-analysis. PLoS One 2021 (published online Feb 5)

Adaken C, Scott JT, Sharma R, et al. Ebola virus antibody decay–stimulation in a high proportion of survivors. Nature 2021 Jan 27;151

Ali E, Benedetti G, van den Bergh R, Halford A, et al. Distribution of household disinfection kits during the 2014-2015 Ebola virus outbreak in Monrovia, Liberia: the MSF experience. PLoS Negl Trop Dis 2020 (published online Sep 21)

Atherstone C, Diederich S, Pickering B, et al. Investigation of Ebolavirus exposure in pigs presented for slaughter in Uganda. Transbound Emerg Dis 2020 (published online Sep 11)

Bah AJ, James PB, Bah N, et al. Prevalence of anxiety, depression and post-traumatic stress disorder among Ebola survivors in northern Sierra Leone: a cross-sectional study. BMC Public Health 2020 Sep 11;20(1391)

Bane S, Rosenke K, Maiga O, et al. Ebola virus IgG seroprevalence in southern Mali. Emerg Infect Dis 2021 Jun;27(6)

Barnes KG, Lachenauer AE, Nitido A, et al. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nat Commun 2020 Aug 17;11(4131)

Bond NG, Grant DS, Himmelfarb ST, et al. Post-Ebola syndrome presents with multiple overlapping symptom clusters: evidence from an ongoing cohort study in eastern Sierra Leone. Clin Infect Dis 2021 (published online Apr 3)

Bozman CM, Fallah, M, Sneller MC, et al. Increased likelihood of detecting Ebola virus RNA in semen by using sample pelleting. Emerg Infect Dis 2021 Apr;27(4)

Choi MJ, Cossaboom CM, Whitesell AN, et al. Use of Ebola vaccine: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR 2021 Jan 8;70(1):1-12

Doshi RH, Bratcher A, Mukadi P, et al. Risk factors for Ebola exposure in healthcare workers in Boende, Tshuapa Province, Democratic Republic of the Congo. J Infect Dis 2020 (published online Dec 3)

Eghrari AO, Vishop RJ, Ross RD, et al. Characterization of Ebola virus–associated eye disease. JAMA Netw Open 2021 Jan 5;4(1):e2032216

Fontes CM, Lipes BD, Liu J, et al. Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR. Sci Transl Med 2021 Apr 7;13(588):eabd9696

Goldstein T, Belaganahalli MN, Syaluha EK, et al. Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak. One Health Outlook 2020 Nov 4;2:21

Gryseels S, Mbala-Kingebeni P, Akonda I, et al. Role of wildlife in emergence of Ebola virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017. Emerg Infect Dis (Dispatch) 2020 Sep;26(9)

Higgs ES, Gayedyu-Dennis D, Fisher W, et al. PREVAIL IV: a randomized, double-blind, two-phase, phase 2 trial of remdesivir versus placebo for reduction of Ebola virus RNA in the semen of male survivors. Clin Infect Dis 2021 (published online Mar 12)

Jain V, Charlett A, Grown CS. Meta-analysis of predictive symptoms for Ebola virus disease. PLoS Negl Trop Dis 2020 (published online Oct 23)

Jalloh MF, Kaiser R, Diop M, et al. National reporting of deaths after enhanced Ebola surveillance in Sierra Leone. PLoS Negl Trop Dis 2020 (published online Aug 18)

Kangbai JB, Heumann C, Hoelscher M, et al. Severity score for predicting in-facility Ebola treatment outcome. Ann Epidemiol 2020 (published online Aug 5)

Kinganda-Lusamaki E, Black A, Mukadi DB, et al. Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo. Nat Med 2021 (published online Apr 12)

Kofman A, Linderman S, Su K, et al. Characteristics of Ebola virus disease survivor blood and semen in Liberia: serology and RT-PCR. Clin Infect Dis 2020 (published online Sep 7)

Mahon BE, Simon J, Widdowson MA, et al. Baseline asymptomatic malaria infection and immunogenicity of rVSVΔG-ZEBOV-GP vaccine: the Sierra Leone trial to introduce a vaccine against Ebola (STRIVE).  J Infect Dis 2021 (published online May 20)

Mbala-Kingebeni P, Pratt C, Mutafali-Ruffin M, et al. Ebola virus transmission initiated by relapse of systemic Ebola virus disease. N Engl J Med (Brief report) 2021 Apr 1;384(13):1240-7

Moran Z, Rodriguez W, Ahmadou D, et al. Comparative performance study of three Ebola rapid diagnostic tests in Guinea. BMC Infect Dis 2020 Sep 15;20(670)

Ngo TM, Rogers B, Patnaik R, et al. The effect of Ebola virus disease on maternal and child health services and child mortality in Sierra Leone, 2014-2015: implications for COVID-19. Am J Trop Med Hyg 2021 (published online Jan 4)

Olu OO, Lako R, Bunga S, et al. Analyses of the performance of the Ebola virus disease alert management system in South Sudan: August 2018 to November 2019. PLoS Negl Trop Dis 2020 (published online Nov 3)

Pollard AJ, Launay O, Lelievre JD, et al. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 2020 (published online Nov 17)

Reynard S, Gloaguen E, Baillet N. Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates. PLoS Negl Trop Dis 2021 (published online Mar 29)

Tompkins K, Brown J, Tozay S, et al. The impact of semen testing for Ebola virus RNA on sexual behavior of male Ebola survivors in Liberia. PLoS Negl Trop Dis 2020 (pubslihed online Sep 14)

Winters M, Jalloh MF, Sengeh P, et al. Risk perception during the 2014–2015 Ebola outbreak in Sierra Leone. BMC Public Health 2020 Oct 12;20:1539

Wirsiy FS, Boock AU, Akoachere JF. Assessing the determinants of Ebola virus disease transmission in Baka community of the tropical rainforest of Cameroon. BMC Infect Dis 2021 Apr 7;21:324

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»